Clinical trial
Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With…
NCT00062010 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00062010 |
|---|---|
| Title | Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer |
| Official title | Interferon Alpha (NSC# 377523) Plus 13-Cis-Retinoic Acid Modulation Of BCL-2 Plus Paclitaxel For Recurrent Small Cell Lung Cancer |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological, Drug |
| Interventions | interferon alpha, 13-cis-retinoic acid, paclitaxel |
| Enrollment | 37 |
| Start date | May 26, 2004 |
| Primary completion | May 1, 2011 |
| Completion | Aug 1, 2012 |
| First posted | Jun 6, 2003 |
| Last update posted | Jul 7, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: